Peter Seiler is the founder and owner of P. Seiler Einzelfirma and has over 25 years of experience in the research and development of vaccines and small molecules targeting bacterial and mycobacterial pathogens. He has worked at both large pharmaceutical companies and small- to mid-sized biotech firms in Switzerland and internationally. Peter has led and co-led diverse programmes from hit-to-lead stages to preclinical and clinical development, including NDA preparations. He has also been a founder of startup companies, including refscout.net (exit 2012) and praedpharm.com (founded 2021).
Since 2019, Peter has focused on antibacterial research, contracting for companies and organizations in the development of small molecules and vaccines. He has been an active member of the management team of INCATE since 2023, a knowledge and technology transfer officer at the National Centre of Competence in Research AntiResist in Basel /Switzerland, and is also affiliated with the Hans-Knöll-Institute in Jena /Germany.
Peter received his PhD in infection immunology from ETH Zurich.